Sanjaya Baru | Trust is Gone in India’s Relations With America

The wiser and strategically more adept pharma companies have systematically reduced their dependence on the American market over the past several years

xThe Indian pharmaceutical companies that were not prepared for US President Donald Trump’s latest action of imposing tariffs up to 100 per cent on imported branded and patented pharma drugs from October 1 have no one else but their corporate leadership to blame. They ought to have read the smoke signals in time. Of course, the decision to spare generics, for now, should offer relief to many firms but they should be prepared for the worst even on this front. The wiser and strategically more adept pharma companies have systematically reduced their dependence on the American market over the past several years. American Big Pharma has always